Gabar Health Sciences

Terrance Sky

CEO/President | Global Operations
Mr. Sky has over 20 years of experience in the healthcare industry. As a visionary in the global pharmaceutical and medical device industries, Mr. Sky has accumulated a wealth of experience in cGMP compliance, distribution, business development, managed markets, hospital sales, forecasting, and sales operations. He is a subject matter expert in the areas of pharmaceuticals, medical devices, regulatory affairs, packaging, solid dosage manufacturing, engineering economics, cost analysis, regulation, and compliance.
He is a senior executive who is responsible for overseeing the overall operations and strategic direction of the company. His specific responsibilities include: developing and implementing business plans and strategies to achieve financial operational goals, leading and managing a team of executives and employees, working with the board of directors to set company goals and objectives, managing budgets and financial resources, collaborating with researchers, scientists, and other stakeholders to develop new products and technologies, building and maintaining relationships with customers, partners, and other key stakeholders, overseeing regulatory compliance, and ensuring that the company operates ethically and responsibly.

Kinjal Patel

VP of Business Development | North America and Asia
Mr. Patel has over 20 years of experience in the pharmaceutical industry. He has experience in regulatory compliance, quality control, validation, engineering and automation services, and facility design. He has successfully managed and executed multiple projects consisting of business development, negotiations, strategic planning, cost economics, and personnel management. He is an expert in the FDA Code of Federal Regulation (CFR) Parts 210 & 211. He has provided consulting services to multi-national pharmaceutical companies such as Pfizer, Eli Lilly & Company, Abbott labs, Cardinal Health, Baxter, Tyco/Mallinckrodt, APP Pharmaceuticals, Abraxis Biosciences, and Dentsply.
He is a senior executive who is responsible for identifying and pursuing business opportunities that align with the company’s strategic goals. This may involve identifying potential partnerships, licensing deals, or acquisitions that can help the company grow and diversify its product portfolio. He is also responsible for negotiations and execution of business deals, as well as working with internal teams to ensure that all necessary approvals and due diligence are completed. This also includes developing and implementing strategies for business development, including market research, competitive analysis, and forecasting.

Michael Hines

Chief Financial Officer
Mr. Hines has over 35 years of experience in the financial space. He has worked with top fortune 500 companies providing financial services in both healthcare and other consumer industries.
He is a senior-level executive who is responsible for the financial strategy and direction of the company. He is responsible for managing the organization’s financial resources, developing financial plans and budgets, and analyzing financial data to identify trends and make recommendations for improvement. He works closely with other members of the leadership team to ensure that the organization’s financial goals are aligned with its overall business strategy. He is also responsible for interacting with financial institutions and investors, as well as regulatory agencies.

Ralph Navarro

Senior Advisor of Quality & Technical Compliance

Mr. Navarro has over 25 years of experience in the pharmaceutical and biotech industries. He has extensive experience consulting with pharmaceutical companies both in the US and abroad ensuring that the company’s products and processes meet relevant regulatory requirements. He has extensive experience interfacing with numerous regulatory agencies, implementing corrective and preventive actions, and site wide remediation in response to multiple FDA 483s, Warning Letters, and Consent Decrees.
Mr. Navarro has an industry career which began at the lab bench, and spanned product development, project management, quality control and quality assurance. He has held leadership roles at the Director level with Boehringer Ingelheim, Genzyme, and Meridian Medical Technologies. He holds a Management Certificate in Organizational Leadership through Harvard Business School.
He is a senior executive who is responsible for developing and implementing quality assurance policies and procedures, ensuring that products and services meet specified requirements and standards, overseeing testing and evaluation of products and services, identifying and addressing quality and compliance issues, collaborating with cross-functional teams to continuously improve quality and compliance, leading the resolution of customer complaints, and issues related to quality compliance, maintaining knowledge of industry regulations and standards, and ensuring that the company’s practices align with these requirements, providing technical guidance and support to team members, reporting on quality and compliance metrics to senior leadership.

Dr. Chris Alvarado D.O.

Chief Medical Officer
Dr. Alvarado is a fully trained and licensed U.S. doctor. He is an expert in leading teams in clinical trials, design of trials, conduct and interpret clinical studies to support decisions.
He is a senior executive responsible for the overall medical strategy and direction of the company. This includes the development and oversight of clinical trials for new drugs and therapies, as well as the safety and effectiveness of existing products. The CMO works closely with other members of the company’s leadership team, such as the Chief Executive Officer (CEO) and Chief Scientific Officer, to ensure that the company’s products meet the highest standards of quality and effectiveness. In addition, he is responsible for interacting with regulatory agencies, such as the Food and Drug Administration (FDA), to ensure that the company’s products meet all necessary regulatory requirements.

William Burmeister

Chief Scientific Officier

Mr. Burmeister has over 40 years of experience in the Life Sciences space. He received his training in physiology and joined the division of Cardiovascular Pharmacology at Parke-Davis Pharmaceutical Research where he held various positions of increasing responsibility as a Senior Associate Scientist over two decades. He has conducted research in emerging markets such as Brazil, China, India, Mexico, Puerto Rico, and Vietnam.
He is a senior executive responsible for the overall scientific strategy and direction of the organization. He is responsible for leading and managing the organization’s research and development efforts, as well as overseeing the scientific staff and resources. He works closely with other members of the leadership team, such as the Chief Executive Officer (CEO) and Chief Medical Officer (CMO), to ensure that the organization’s scientific goals and objectives are aligned with its overall business strategy. He is also responsible for interacting with regulatory agencies, such as the Food and Drug Administration (FDA) in the United States, to ensure that the organization’s products or processes meet all necessary regulatory requirements.